全文获取类型
收费全文 | 30710篇 |
免费 | 2006篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 264篇 |
儿科学 | 437篇 |
妇产科学 | 304篇 |
基础医学 | 4582篇 |
口腔科学 | 929篇 |
临床医学 | 2979篇 |
内科学 | 7384篇 |
皮肤病学 | 454篇 |
神经病学 | 3480篇 |
特种医学 | 1857篇 |
外科学 | 4159篇 |
综合类 | 177篇 |
一般理论 | 11篇 |
预防医学 | 1258篇 |
眼科学 | 625篇 |
药学 | 1711篇 |
中国医学 | 52篇 |
肿瘤学 | 2211篇 |
出版年
2024年 | 28篇 |
2023年 | 264篇 |
2022年 | 438篇 |
2021年 | 816篇 |
2020年 | 505篇 |
2019年 | 705篇 |
2018年 | 787篇 |
2017年 | 613篇 |
2016年 | 873篇 |
2015年 | 989篇 |
2014年 | 1240篇 |
2013年 | 1525篇 |
2012年 | 2493篇 |
2011年 | 2504篇 |
2010年 | 1501篇 |
2009年 | 1345篇 |
2008年 | 2206篇 |
2007年 | 2212篇 |
2006年 | 2137篇 |
2005年 | 2009篇 |
2004年 | 1746篇 |
2003年 | 1643篇 |
2002年 | 1535篇 |
2001年 | 267篇 |
2000年 | 195篇 |
1999年 | 280篇 |
1998年 | 304篇 |
1997年 | 224篇 |
1996年 | 164篇 |
1995年 | 151篇 |
1994年 | 122篇 |
1993年 | 87篇 |
1992年 | 62篇 |
1991年 | 60篇 |
1990年 | 38篇 |
1989年 | 56篇 |
1988年 | 36篇 |
1987年 | 31篇 |
1986年 | 33篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 34篇 |
1982年 | 34篇 |
1981年 | 28篇 |
1980年 | 26篇 |
1938年 | 24篇 |
1937年 | 30篇 |
1936年 | 25篇 |
1935年 | 35篇 |
1934年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Stefan I McDonough 《Toxicon》2007,49(2):202-212
Some of the most potent and specific inhibitors of voltage-gated calcium channels are peptide toxins that inhibit channel function not by occlusion of the channel pore, but rather by interfering with the voltage dependence and kinetics of channel opening and closing. Many such gating modifier toxins conform to the inhibitor cystine knot structural family and have primary sequence or functional mechanism similar to toxins that target voltage-gated sodium or potassium channels. This review introduces known gating modifiers of calcium channels, discusses the selectivity, binding sites, and mechanism of the toxin-channel interaction, and reviews the usefulness of these toxins as research tools and as the basis for novel calcium channel pharmacology and therapeutics. 相似文献
33.
Andreas Blana Stefan Denzinger Markus Lenhart Wolf F Wieland Roman Ganzer 《International journal of urology》2007,14(5):450-451
We report a case of recurrent inguinal lymphocele formation after inguinal lymphadenectomy treated by lymphographic mapping and selective ligation of the lymphatic vessels. Lymphographic mapping was performed by puncturing a lymphatic vessel at the dorsum of the foot. After isolating the vessels that drained into the lymphocele, they were clipped and divided through a small skin incision. The described technique showed an instant and complete suspension of the lymph secretion with subsequent complete healing. Lymphatic mapping and selective ligation of afferent lymphatic vessels proved to be an effective treatment of a recurrent inguinal lymphocele. 相似文献
34.
35.
36.
37.
A number of cross-over studies on sedation in outpatient oral surgery investigated the quality of sedation produced by intravenous or rectal administration of diazepam. The sedation methods were equally efficient with a mean dose of 0.24 mg/kg (range 0.1–0.4) for i.v. administration and 0.53 mg/kg (range 0.5–0.6) for rectal administration. Eighty-five percent of the patients preferred surgery under sedation and local anaesthesia to local anaesthesia alone. The patients preferred the session in which they experienced stronger sedation, regardless of the route of administration. 相似文献
38.
Katalin Vehmeyer Tibor Hajto Katarina Hostanska Stefan Knemann Holger Lser Reinhard Saller Bernhard Wrmann 《European journal of haematology》1998,60(1):16-20
Abstract: The galactoside-specific plant lectin, Viscum album agglutinin (VAA-I) increases cellular parameters of natural host defence. It also binds to a variety of haematopoietic cells, including progenitors. We investigated whether VAA-I has a stimulatory effect on haematopoietic progenitor cells. Peripheral blood progenitor cells from 7 healthy volunteers were cultured in a colony assay with VAA-I plus erythropoietin (EPO) and stem cell factor (SCF). At 50 pg/ml VAA-I induced a significant increase in the cytokine-dependent clonogenic growth (52% in median, p<0.05). In another set of experiments purified CD34+ cells were isolated from the bone marrow aspirate of 4 patients with non-metastatic breast cancer using fluorescence-activated cell sorting. Binding to CD34+ cells was demonstrated by using directly fluorescence-conjugated VAA-I. Co-incubation with d -galactose significantly abrogated this effect. CD34+ cells were cultured in the presence of EPO, SCF, interleukin-3, granulocyte/monocyte colony-stimulating factor and granulocyte colony-stimulating factor. VAA-I alone had no measurable effect on the clonogenic growth of the isolated cells. However, at concentrations of 100 and 250 pg/ml VAA-I increased the cytokine-dependent proliferation and differentiation of CD34+ cells by a median of 75 and 85%, respectively. The results show that VAA-I binds to haematopoietic progenitor cells and has a co-stimulatory effect on their proliferation. 相似文献
39.
Christian Boewer Gottfried Enderlein Udo Wollgast Stefan Nawka Hubert Palowski Renate Bleiber 《International archives of occupational and environmental health》1988,60(3):181-186
Summary In a cross-sectional study of 181 male workers of a rotogravure printing plant, most of whom were exposed to toluene levels well above the GDR threshold limit values, 55 subjects revealed pathological liver screening values (activities of serum aspartate aminotransferase, alanine amino-transferase, gamma glutamyltransferase; liver size). The differential diagnostic examination showed in 51 out of these 55 subjects an association with competing factors such as alcohol abuse (78%) and overweight (40%), to a slight extent disorders of fat and carbohydrate metabolism and of the gallbladder. Drug intake did not play any role. The variance and regression analyses of the biochemical data have shown that alcohol significantly and considerably increases the activities of all three enzymes tested. Bodyweight had a similar, but less pronounced, significant effect. On the other hand, in subjects with a higher alcohol intake the activities of liver enzymes in highly toluene exposed subgroups were significantly and clearly lower than among slightly toluene exposed workers. 相似文献
40.
Andrea von Berg Renate Engelstätter Predrag Minic Miodrag Sréckovic Maria Luz Garcia Garcia Tadeusz Lato Jan H. Vermeulen Stefan Leichtl Stefan Hellbardt Thomas D. Bethke 《Pediatric allergy and immunology》2007,18(5):391-400
Ciclesonide is an onsite-activated inhaled corticosteroid (ICS) for the treatment of asthma. This study compared the efficacy, safety and effect on quality of life (QOL) of ciclesonide 160 microg (ex-actuator; nominal dose 200 microg) vs. budesonide 400 microg (nominal dose) in children with asthma. Six hundred and twenty-one children (aged 6-11 yr) with asthma were randomized to receive ciclesonide 160 microg (ex-actuator) once daily (via hydrofluoroalkane metered-dose inhaler and AeroChamber Plus spacer) or budesonide 400 microg once daily (via Turbohaler) both given in the evening for 12 wk. The primary efficacy end-point was change in forced expiratory volume in 1 s (FEV1). Additional measurements included change in daily peak expiratory flow (PEF), change in asthma symptom score sum, change in use of rescue medication, paediatric and caregiver asthma QOL questionnaire [PAQLQ(S) and PACQLQ, respectively] scores, change in body height assessed by stadiometry, change in 24-h urinary cortisol adjusted for creatinine and adverse events. Both ciclesonide and budesonide increased FEV1, morning PEF and PAQLQ(S) and PACQLQ scores, and improved asthma symptom score sums and the need for rescue medication after 12 wk vs. baseline. The non-inferiority of ciclesonide vs. budesonide was demonstrated for the change in FEV1 (95% confidence interval: -75, 10 ml, p = 0.0009, one-sided non-inferiority, per-protocol). In addition, ciclesonide and budesonide showed similar efficacy in improving asthma symptoms, morning PEF, use of rescue medication and QOL. Ciclesonide was superior to budesonide with regard to increases in body height (p = 0.003, two-sided). The effect on the hypothalamic-pituitary-adrenal axis was significantly different in favor of ciclesonide treatment (p < 0.001, one-sided). Both ciclesonide and budesonide were well tolerated. Ciclesonide 160 microg once daily and budesonide 400 microg once daily were effective in children with asthma. In addition, in children treated with ciclesonide there was significantly less reduction in body height and suppression of 24-h urinary cortisol excretion compared with children treated with budesonide after 12 wk. 相似文献